Kyowa Kirin International plc.

At KKI, we know that when we prioritise our wellbeing, we thrive as individuals and as a community. Our recent Four Months of Wellbeing (4MOW) initiative was designed to inspire colleagues across the region to embed healthier habits, foster connection, and improve mental and emotional health. Over four months, we focused on specific aspects of wellbeing, with engaging weekly sessions on: 👉 Mindfulness & Meditation: Using tools to build resilience in daily life 👉 Mental Health & Wellbeing: Exploring mental health in a digital age 👉 Belonging: Embracing identity and community 👉 Physical Wellbeing: Exploring the impact of nutrition, exercise and the workplace on health Throughout the campaign, we were delighted to see enthusiastic participation from over 850 attendees, hearing from speakers including our President Jeremy Morgan, Chief International Business Officer and Managing Executive Officer Abdul Mullick, digital wellbeing expert Alessandra L. and cognitive hypnotherapist, Suzette Shahmoon.   4MOW has been a transformative journey! We look forward to applying the valuable lessons learned – both in our personal lives and in the work we do for patients. See below to read some key takeaways our 4MOW participants shared with us. #KKIMakingPeopleSmile #WorkplaceWellbeing

We’re thrilled to announce the successful completion of our latest intern recruitment cycle! 🎉 Since launching in 2023 with just two interns, our programme has gone from strength to strength. This year, we originally planned to welcome eight interns into our 2025 cohort, but the talent pool was so outstanding that we couldn’t resist expanding – bringing 10 exceptional new hires into the fold! And we’re not stopping there! For our 2026 intake, we’re aiming even higher, with plans to increase our intern intake by an impressive 50%! The feedback from academic institutions across the UK has been phenomenal. They’ve praised not only the seamless and inclusive recruitment process but also the supportive, nurturing environment we’ve built – one where people truly take care of each other and where we always make room for a smile 😊 To all our new interns – welcome! We can’t wait to see the impact you’ll make. And to everyone who applied, thank you for your enthusiasm and passion. The future looks bright! #KKIMakingPeopleSmile #KKICareers #FutureTalent

Did you know that 70% of the global health workforce are women, but women are underrepresented in senior healthcare roles and earn on average 28% less than men? When it comes to gender parity in the healthcare industry, we still have a long way to go. Following International Women’s Day, we held a thought-provoking panel discussion with colleagues from across the region to examine the current gaps in gender equality, and how we as a healthcare company can address these issues head on. With thanks to our hosts Céline Rhême and Olivia Kager and our panellists Angela Williams, Daniel Davies, Emilie Bugeat Toussaint and Steve Cumming for an insightful, far-ranging discussion covering the role of unconscious bias in the workplace, how real word data can drive gender equality, and the importance of allyship to foster lasting change. At KKI, our commitment to gender equality extends beyond one day of awareness. We will continue doing all we can do to #AccelerateAction all year round, for our colleagues, our loved ones and the patients we serve. #KKIMakingPeopleSmile 

For this International Women’s Day, we are all called to #AccelerateAction – in our lives, our work, and how we uplift others. To honour this day and its significance, we asked three of our global colleagues to share what #AccelerateAction means to them. We’re proud to share their inspiring perspectives. #InternationalwomensDay 

We were excited to attend this year’s Patient Centricity & Collaboration World Congress which took place in London last week. Two of our DACH (Germany, Austria, and Switzerland) colleagues, Dr. Holger Storcks, Director of Public Affairs & Patient Advocacy, and "Nina" Christiane Sonntag, Patient Services Manager, took to the stage to talk about our XLH Care Patient Support Program (PSP). Hear from Holger and Nina about how the PSP is making a meaningful difference to the lives of children and adults living with #XLH in Germany🎥 #KKIMakingPeopleSmile #KyowaKirin #LifeChangingValue

Join us in celebrating International Women's Day!  Kyowa Kirin's Chief People Officer, Shoko Itagaki, shares her inspiring message on the importance of women's health, wellbeing, and breaking down barriers. 💪 Let's #AccelerateAction for a more inclusive future! 💜

As Rare Disease Month draws to a close, and to mark yesterday’s Rare Disease Day, The Telegraph recently spoke with two of Kyowa Kirin’s leaders, Angela Williams, Global Health Economics and Outcomes Research Head, and Ernesto Aycardi, Global Head of Development. They spoke about how patient partnerships are helping shape treatment breakthroughs in the rare disease space. Their discussion highlights a core truth: meaningful innovation in rare disease starts with putting patient experiences front and centre. Read the full article to learn more about the importance of collaborative approaches in rare disease research. This supplement is fully funded by Kyowa Kirin. #RareDiseaseMonth #KKIMakingPeopleSmile

As an ally to those affected, we are proud to once again participate in EURORDIS’s #LightUpForRare campaign and asked our colleagues worldwide to collectively light up for the millions of people who live with a #raredisease. Kyowa Kirin is united in our commitment to delivering for the rare disease community. We refuse to stand still in our mission to make more people smile. #KKIMakingPeopleSmile

During the month of February, at Kyowa Kirin we are focused on supporting the rare disease community in its efforts to amplify awareness. Abdul Mullick, Chief International Business Officer and Managing Executive Officer, Kyowa Kirin, shares what equity in care and opportunity means to him – the third of this year’s rare disease day themes. #KKIMakingPeopleSmile #RareDiseaseDay 

In Paris, leading experts in rare diseases and public health came together for a crucial roundtable on newborn screening—one of the most powerful tools in accelerating diagnosis and transforming patient outcomes. With France introducing nationwide sickle cell disease screening in November 2024 and planning to add SCID (severe combined immunodeficiency) and SMA (spinal muscular atrophy) by mid-2025, critical questions remain, including: how can we ensure faster, more equitable access to life-changing diagnoses? Emilie Bugeat Toussaint, President of Kyowa Kirin France & BeNeLux, who joined the roundtable, emphasised that the pharmaceutical industry must step up as a key player in early diagnosis of rare diseases—not only by supporting cross-functional initiatives but also by forging private-public partnerships and driving innovation. KKI is proud to be part of this movement, working alongside experts to encourage the development and expansion of newborn screening. *** À Paris, des experts en maladies rares et en santé publique se sont réunis pour une table ronde essentielle sur le dépistage néonatal—un levier majeur pour accélérer le diagnostic et améliorer la prise en charge des patients. Alors que la France a introduit un dépistage national de la drépanocytose en novembre 2024 et prévoit d’ajouter le DICS (le déficit immunitaire combiné sévère) et l’SMA (l'atrophie musculaire spinale) d’ici la mi-2025, des questions cruciales persistent, notamment: comment garantir un accès plus rapide et plus équitable à des diagnostics qui changent des vies? Emilie Bugeat Toussaint, Présidente de Kyowa Kirin France & BeNeLux, qui s'est jointe à la table ronde, a insisté sur le fait que l’industrie pharmaceutique doit jouer un rôle clé dans le diagnostic précoce des maladies rares —non seulement en soutenant les initiatives existantes, mais aussi en construisant des partenariats public-privé et en favorisant l’innovation. KKI est fier de contribuer à cette dynamique, aux côtés des experts, pour favoriser l’évolution et l’élargissement du dépistage néonatal. #KKIMakingPeopleSmile #RareDiseases #MaladiesRares #LifeChangingValue #DiagnosticPrécoce